Derzeit leiden ca. 200 Millionen Menschen weltweit an einer peripheren arteriellen Verschlusskrankheit, kurz pAVK. Erhalten Patienten im Verlauf der Erkrankung einen revaskularisierenden Eingriff, wird eine präventive antithrombotische Therapie eingeleitet. Aktuell erfolgt diese leitliniengerecht mit ASS oder Clopidogrel. Doch reicht diese Medikation aus, um ... Show More
Jan 2025
Antiplatelets, Anticoagulants, and Thrombolytics
Send us Fan MailNinja Nerds!Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we explore Antiplatelets, Anticoagulants, and Thrombolytics, focusing on their mechanisms and clinical uses. Topics include the pharmacology of antiplatelet agents such as aspirin an ... Show More
47m 19s
Nov 2022
Anticoagulants, Thrombolytics, and Antiplatelet Agents
Send us Fan MailThis week, Rob and Zach will be talking about Anticoagulants, Thrombolytics, and Antiplatelet AgentsWe will be discussing the following topics within this episode on Anticoagulants, Thrombolytics, and Antiplatelet Agents!Hemostasis: Coagulation Cascade, Extrinsic ... Show More
1h 13m
Apr 2021
#85 Dual Antiplatelet Therapy: 5 Pearls Segment
How does cost, potency, and bleeding risk affect which antiplatelet you choose P2Y12 inhibitors? How long after starting, do you feel comfortable stopping DAPT on a patient? How do you manage DAPT in patients who need anticoagulation?Show notes, Transcript and References: https:/ ... Show More
35m 54s